Full text

Turn on search term navigation

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Biological activities, including cell viability, oxidative stress, genotoxicity/antigenotoxicity, and antimicrobial activity, were evaluated for a visible-light-responsive TiO2-based ICT complex with dihydroquercetin (DHQ) and compared with pristine TiO2, its inorganic component. Pristine TiO2 did not induce cytotoxicity in MRC-5 or HeLa cells within the tested concentration range (1–20 mg/mL), while TiO2/DHQ displayed a significant reduction in cell viability in both cell lines at higher concentrations (≥10 mg/mL). The analysis of reactive oxygen species (ROS) production revealed that TiO2/DHQ significantly reduced ROS levels in both cell types (MRC-5 and HeLa), with HeLa cells showing a more substantial reduction at lower concentrations. Genotoxicity assessment using the comet assay demonstrated that TiO2 induced DNA damage in MRC-5 cells, while TiO2/DHQ did not, indicating that DHQ mitigates the genotoxic potential of TiO2. Furthermore, TiO2/DHQ exhibited antigenotoxic effects by reducing H2O2-induced DNA damage in MRC-5 cells, supporting its protective role against oxidative stress. Preliminary antimicrobial tests revealed that TiO2/DHQ exhibits antimicrobial activity against E. coli under visible-light excitation, while TiO2 does not. These findings suggest that the TiO2-based ICT complex with DHQ with enhanced antioxidant properties can potentially serve as a safe, non-toxic biocide agent.

Details

Title
Bioactivity Assessment of Functionalized TiO2 Powder with Dihydroquercetin
Author
Nikšić, Valentina 1   VIAFID ORCID Logo  ; Pirković, Andrea 2   VIAFID ORCID Logo  ; Spremo-Potparević, Biljana 3 ; Živković, Lada 3 ; Topalović, Dijana 3   VIAFID ORCID Logo  ; Nedeljković, Jovan M 1 ; Lazić, Vesna 1   VIAFID ORCID Logo 

 Vinča Institute of Nuclear Sciences—National Institute of the Republic of Serbia, Centre of Excellence for Photoconversion, University of Belgrade, 11351 Belgrade, Serbia; [email protected] (V.N.); [email protected] (J.M.N.) 
 Department for Biology of Reproduction, INEP Institute for Application of Nuclear Energy, University of Belgrade, 11080 Belgrade, Serbia; [email protected] 
 Department of Pathobiology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia; [email protected] (B.S.-P.); [email protected] (L.Ž.); 
First page
1475
Publication year
2025
Publication date
2025
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171024857
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.